Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Drexel

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
European Journal of Clinical Investigation|July 20, 2007
Leptin, leptin soluble receptor and coronary atherosclerosisG Hoefle, C H Saely, L Risch, et al.
Diabetologia|January 1, 1993
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitusA Császár, H Dieplinger, C Sandholzer, et al.
Diabetologia|November 30, 2011
Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?A Othman, M F Rütti, D Ernst, et al.
Wiener Klinische Wochenschrift|October 8, 1999
[Secondary prevention following coronary intervention. Survey of 13 intervention centers in Austria]H Drexel, G B Gaul, G Grimm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Gender differences in the effects of cardiovascular drugsJ Tamargo, G Rosano, T Walther, et al.
Diabetes, Obesity & Metabolism|January 29, 2024
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trialCaren Sourij, Abderrahim Oulhaj, Faisal Aziz, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
European Journal of Clinical Investigation|July 20, 2007
Leptin, leptin soluble receptor and coronary atherosclerosisG Hoefle, C H Saely, L Risch, et al.
Diabetologia|January 1, 1993
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitusA Császár, H Dieplinger, C Sandholzer, et al.
Diabetologia|November 30, 2011
Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?A Othman, M F Rütti, D Ernst, et al.
Wiener Klinische Wochenschrift|October 8, 1999
[Secondary prevention following coronary intervention. Survey of 13 intervention centers in Austria]H Drexel, G B Gaul, G Grimm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Gender differences in the effects of cardiovascular drugsJ Tamargo, G Rosano, T Walther, et al.
Diabetes, Obesity & Metabolism|January 29, 2024
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trialCaren Sourij, Abderrahim Oulhaj, Faisal Aziz, et al.
Pageof 10